UnitedHealth Group Incorporated (UNH) Shares Sold by RKL Wealth Management LLC

RKL Wealth Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,327 shares of the healthcare conglomerate’s stock after selling 576 shares during the period. RKL Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,167,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Regal Wealth Group Inc. grew its stake in UnitedHealth Group by 0.4% during the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after acquiring an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. lifted its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after acquiring an additional 4 shares during the last quarter. RB Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after acquiring an additional 7 shares during the last quarter. Altfest L J & Co. Inc. lifted its holdings in shares of UnitedHealth Group by 0.3% in the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after acquiring an additional 10 shares during the last quarter. Finally, Hanson McClain Inc. lifted its holdings in shares of UnitedHealth Group by 1.7% in the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after acquiring an additional 15 shares during the last quarter. Institutional investors and hedge funds own 86.20% of the company’s stock.

A number of brokerages have recently weighed in on UNH. Leerink Swann restated a “buy” rating and issued a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a report on Thursday, September 21st. Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday, October 18th. Finally, Wells Fargo & Company reaffirmed an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Three equities research analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $224.56.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $5.36 during trading on Tuesday, reaching $221.42. 5,591,400 shares of the company’s stock were exchanged, compared to its average volume of 3,118,647. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market cap of $213,740.00, a P/E ratio of 23.62, a P/E/G ratio of 1.68 and a beta of 0.66. UnitedHealth Group Incorporated has a fifty-two week low of $156.09 and a fifty-two week high of $231.77.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.17 EPS. sell-side analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s payout ratio is currently 34.09%.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last three months, insiders have sold 57,606 shares of company stock worth $11,566,525. Insiders own 0.89% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Shares Sold by RKL Wealth Management LLC” was originally reported by Transcript Daily and is the property of of Transcript Daily. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://transcriptdaily.com/2017/12/05/unitedhealth-group-incorporated-unh-shares-sold-by-rkl-wealth-management-llc.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply